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ABSTRACT
OBJECTIVES: To determine the efficacy and safety of the use of cryotherapy, cold knife or 
thermocoagulation compared to Loop Electrosurgical Excision Procedure (LEEP) for the 
treatment of cervical intraepithelial neoplasia.
METHODS: Systematic review with meta-analysis of randomized controlled trials in women 
with cervical intraepithelial neoplasia undergoing treatment with cryotherapy, cold knife, or 
thermo-coagulation compared with LEEP, to estimate its efficacy and safety. The search was 
conducted on MEDLINE/PUBMED, Cochrane Central Register of Controlled Trials (CENTRAL) 
and Scopus, until September 2018.
RESULTS: The total of 72 studies were identified, of which only 8 studies met the inclusion 
criteria. The treatment of CIN with cold knife decreases the risk of residual disease compared 
with LEEP (RR, 0.54, 95%CI, 0.30–0.96, p = 0.04). The management of premalignant lesions with 
cryotherapy, compared with LEEP, increases the risk of disease recurrence by 86% (RR, 1.86, 
95%CI, 1.16–2.97, p = 0.01), increases the risk of infections (RR, 1.17, 95%CI, 1.08–1.28, p < 0.001) 
and reduces the risk of minor bleeding by 51% (RR, 0.49, 95%CI) %, 0.40–0.59, p ≤ 0.001).
CONCLUSIONS: The treatment of premalignant lesions of cervical cancer with cold knife 
reduces the risk of residual disease. Nevertheless, cryotherapy reduces the risk of minor bleeding 
in the 24 hours after treatment and increases the risk of recurrence of disease and infections.
DESCRIPTORS: Cervical Intraepithelial Neoplasia, therapy. Cryotherapy. Conization. 
Electrosurgery. Uterine Cervical Neoplasms. Systematic Review.
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INTRODUCTION
Cervical cancer is the fourth most common type of cancer and the fourth leading cause 
of death in women worldwide1. However, cervical cancer still ranks as the second leading 
cause of death and the second most common cancer in the female population in low and 
middle income countries1. Cervical intraepithelial neoplasia (CIN) is a premalignant 
lesion of cervical cancer, histologically divided as CIN1, CIN2 and CIN3. Both these 
premalignant lesions and cancer in situ are attributed to human papillomavirus (HPV)2,3. 
According to the International Agency for Research on Cancer (IARC), report of 20184, 
in Peru, oncogenic HPV types 16 and 18 are found in 6.6% of patients with normal 
cytology, 27.3% with CIN1, 53.1% with CIN2-3 and 65.9% with cancer in situ. Early 
diagnosis and management of these pre-malignant lesions helps reduce the natural 
progression of these lesions into cervical uterine cancer. Monitoring of CIN2 and CIN3 
histological lesions becomes a fundamental task in public health given that 31.0% of 
these evolve into cancer in the following 30 years5. Timely and appropriate therapeutic 
intervention can reduce this risk. Some authors have shown in monitoring cohorts of 
10–20 years that the post-treatment rate of premalignant lesions decreases more than 
30.0% during the first 10 years6,7.
For the treatment of premalignant cervical lesions, both ablative methods (cervical 
cryotherapy, laser ablation) and excisional methods (Loop Electrosurgical Excision 
Procedure (LEEP), cold cone) can be effective. As recommended by the World Health 
Organization guidelines in the clinical guide published in 20158, cryotherapy treatment is 
recommended for patients with CIN2+ lesions. If the patient is not eligible for this ablative 
therapy, the use of LEEP is recommended. However, excision and ablation procedures may 
be associated with adverse outcomes. Therefore, the objective of this systematic review and 
meta-analysis was to assess the effectiveness and safety of treating CIN with cryotherapy, 
cold cone or thermocoagulation compared to LEEP.
METHODS
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines 
were applied in the development and reporting of this systematic review9.
Randomized controlled trials (RCT) were considered eligible (as the objective was to 
assess efficacy and safety) that met the following criteria: study population women 
over 18 years old with diagnosed cervical intraepithelial neoplasia and treatment 
interventions with cryotherapy, cold cone, or thermocoagulation and LEEP as comparator. 
Studies were excluded if participants were pregnant women, women with HIV (Human 
Immunodeficiency Virus) infection, women with symptoms or a history of treatment and 
monitoring of cervical cancer.
The variables to assess effectiveness were: residual disease (in less than six months), 
recurrent disease (in more than six months) and positive margins. Major bleeding 
(hospitalization or blood transfusion), minor bleeding (bleeding not requiring 
hospitalization or blood transfusion after 24 hours after treatment), mortality associated 
with treatment, cervical stenosis, pain in treatment area, infections related to the 
procedure (requiring hospitalization or antibiotics) and damage to other organs or need 
for other surgeries were assessed.
We reviewed the MEDLINE/PUBMED, Cochrane Central Register of Controlled Trials 
(CENTRAL) The Cochrane Library and Scopus databases, using “Medical Subject Headings 
(MeSH)” or equivalent terms and text word terms. Articles in English and Spanish were 
included. A preliminary search strategy was created for MEDLINE/PUBMED. The remaining 
searches were tailored to individual databases (Table 1), and the search was conducted from 
January 1993 to September 2018 (last 25 years). Additionally, we assessed the bibliographic 
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references of the selected articles to identify other articles related to our systematic review. 
We used a broad search strategy aiming to increase sensitivity and identifying a relevant 
number of articles related to our research question. We developed the following MEDLINE 
search strategy:
#1 (“Uterine Cervical Neoplasms”[Mesh]) OR ((“Uterine Cervical”[tiab] OR cervix[tiab]) 
AND (cancer[tiab] OR tumor[tiab] OR neoplasm[tiab] OR carcinoma[tiab] 
OR malignancy[tiab]))
#2 “Loop Electrosurgical Excision Procedure”[tiab] OR “Large loop excision of the 
transformation zone”[tiab] OR “LEEP”[tiab] OR “LLETZ”[tiab]
#3 “cryotherapy”[MeSH Terms] OR cryotherapy[tiab]
#4 “cold coagulation”[tiab]
#5 “conization”[MeSH Terms] OR “conization”[tiab]
#6 “Randomized Controlled Trial” [pt] OR “Randomized Controlled Trial”[tiab]
#7 #3 OR #4 OR #5
#8 #1 AND #2 AND #7
#9 #8 AND #6
For the databases Scopus, and The Cochrane Library the search strategy was developed 
with the terms: “Uterine Cervical Neoplasms,” “Loop Electrosurgical Excision Procedure” 
and “Randomized Controlled Trial.”
Study selection and data collection
Two reviewers independently assessed study eligibility based on titles and abstracts 
(YHR and NBC); discrepancies were solved by a third reviewer ( JG). Titles and 
abstracts of all selected references were independently assessed by applying the 
objectives and research question (PICO). We manually reviewed all references in the 
selected full texts.
According to the search criteria in the different pre-selected databases, the references 
of each database that met the search criteria were exported to the Zotero software. 
Duplicates were eliminated and the required information (description of the 
methodology, results and conclusions) was extracted independently. Review Manager 
5.3 (RevMan 5.3, Copenhagen, The Cochrane Collaboration) was used to extract the 
main data10.
To assess the risk of bias of each of the studies, we used the tool proposed by Higgins11, 
following the methodology of the Cochrane Collaboration. This assessment included the 
domains: sequence generation, assignation concealment, blinding, incomplete outcome 
data, and selective outcome reporting and other sources of bias.
The GRADE (Grading of Recommendations Assessment, Development and Evaluation)12 
methodology was used to assess the certainty of the evidence for each outcome. This 
assessment included the risk of bias, inconsistency, imprecision, indirect evidence and 
other considerations13.
Quantitative synthesis of eligible studies for binary outcomes was performed using a 
fixed effects model allowing the estimation of pooled RR and 95% confidence intervals of 
the effect of treatments for CIN from similar studies. Random effects sensitivity analyses 
were performed if the results were heterogeneous (I2 > 50%). Heterogeneity tests (using the 
chi-square test of heterogeneity and the I2 statistical test) were performed for each of the 
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Table 1. Characteristics of the studies included (1993–2018).
Study
Intervention
Histology
Study 
design
Study 
Period
Country
Monitoring 
Time
Type of 
study 
center
Professional 
who did the 
procedure
Outcome
Cold 
Cone
Cryotherapy LEEP
Chirenje 
2001 
- 200 200 NIC 2-3 RCT 1997–1998 Zimbabwe 12 months
Screening 
Center
Gynecologist
Disease recurrence (after 
6 months of treatment) 
and Residual disease 
(within 6 months of 
treatment) 
Mitchell 
1998
- 139 130 NIC 1-3 RCT 1992–1994 EUA 24 months
Specialized 
center
Three 
gynecologists, 
two family 
doctors and 
two nurse 
practitioners
Recurrence of illness 
(after 6 months of 
treatment), residual 
illness (within 6 months 
of treatment), cervical 
stenosis (requiring 
dilation), minor bleeding 
(requiring hospital 
visit), secondary pain 
(requiring medication) 
and infections (requiring 
antibiotic treatment).
Duggan 
1999
89 - 91 NIC 1-3 RCT 1992–1994 EUA 12 months
Specialized 
women's 
hospital
Gynecology 
residents, 
with direct 
supervision by 
the researcher
Recurrence of illness 
(NS), Residual illness 
(NS), Minor bleeding 
(up to 6 weeks post-op), 
Cervical stenosis (NS), 
Infections (NS).
Giacalone 
1999
38 - 28 NIC 2-3 RCT 1997–1998 France 3 months
University 
Hospital
Trained 
physician
Residual disease (NS), 
Secondary bleeding 
(requiring hospital 
visit), positive margins 
and cervical stenosis 
(inability to insert Heger 
dilator Nº3).
Girardi 
1994
38 - 52 NIC 1-3 RCT unspecified Austria 10 months University Not specified
Recurrence of illness 
(up to 8 or 10 months), 
minor bleeding (NS)
Mathevet 
1994
37 - 36 NIC 1-3 RCT 1990–1992 Canada 6 months
General 
Hospital
Trained 
physicians
Residual disease 
(NS), cervical stenosis 
(inability to insert a 
Heger Nº3 dilator), 
minor bleeding (NS) and 
positive margins.
Mathevet 
2003
37 - 36 NIC 1-3 RCT 1990–1992 Canada 65 months
General 
Hospital
Trained 
physicians
Residual disease, 
cervical stenosis, minor 
bleeding and positive 
margins.
Takac 
1999
120 - 120 NIC 1-3 RCT 1993–1996 Slovenia 3 months
Specialized 
hospital
Not specified
Residual disease (up 
to 3 months), minor 
bleeding (NS).
LEEP (Loop Electrosurgical Excision Procedure)
RCT: Randomized clinical trial. CIN: Cervical intraepithelial neoplasia.
NS: Not Specified
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outcomes. Heterogeneity was accepted if I2 > 50% and 0.1 p was selected as the cutting point 
for rejecting the null hypothesis of the study’s homogeneity14.
This study did not require ethics committee approval because it is not an identifiable data 
or individual data.
RESULTS
Seventy-two scientific articles were identified: 66 of the records identified through 
database searching (Cochrane = 22, PubMed = 19 and Scopus = 25) and six using 
additional records identif ied by other sources. After eliminating duplicates, 51 
records were left for abstract reading, with 42 articles eliminated. After applying the 
selection criteria and after reading the full text, eight original articles were selected15–21 
(Table 1). The article by Huang et al.22 was excluded because it was not a randomized 
controlled study. Of the studies included, 57.0% had adequate randomized generation 
of the sequence and clearly described the method of allocation concealment; 29.0% 
carried out a blinding of participants and staff and blinding of the assessment of the 
event. Four studies had incomplete data to assess at the end of treatment which would 
generate a risk of bias due to loss to follow-up. Three of the studies did not clearly 
specify the outcomes to be assessed, so this was considered a high risk of reporting bias 
(Figure 1). A better rating of the assessment of risk of bias could be seen in the studies 
by Duggan et al.19, Giacalone et al.15, and Mitchell et al.17.
Six of the included studies assessed treatment of CIN with cold cone compared with 
LEEP15,16,19–21, two studies assessed treatment with cryotherapy compared to LEEP17,18. No 
studies were identified assessing treatment of CIN with thermocoagulation compared 
with LEEP. Regarding the comparison between Cold Cone versus LEEP, the certainty of the 
evidence was very low for all outcomes (Table 2). For the comparison between cryotherapy 
and LEEP, with the exception of the Minor Bleeding outcome after the first 24 hours post 
treatment which was of moderate certainty, the other outcomes were of low or very low 
certainty (Table 2).
Three of the six included studies assessed disease recurrence19,20,23. The prevalence of disease 
recurrence after cold cone treatment was 2.0% and in patients treated with LEEP, 7.1%. 
The study by Girardi et al.20 did not identify any cases of disease recurrence in any of the 
patients treated with cold cone or LEEP. Meta-analysis of the studies showed no statistically 
significant difference in risk of disease recurrence between patients treated for CIN with 
cold cone compared to LEEP (RR 0.32, 95%CI, 0.09–1.14, p = 0.08). The studies showed no 
significant heterogeneity (P = 0.65 and I2 = 0%) (Figure 2A).
Figure 1. Domain Summary of Bias Risk Assessment according to the Cochrane Tool (1993–2018).
0% 25% 50% 75% 100%
Other biases
Selective reporting
Incomplete outcome assessment
Blinding of outcome assessment
Blinding of participants and personnel
Allocation concealment
Random sequence generation
Low risk Unclear risk High risk 
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Four studies assessed residual disease15,16,19,21. Residual disease was reported in 6.1% of 
patients treated with cold cone and in 11.2% of those treated with LEEP. Meta-analysis of 
all four studies showed that patients treated with cold cone were less likely to have residual 
disease compared to those treated with LEEP (RR 0.54, 95%CI, 0.30–0.96, p = 0.04). The 
studies showed no significant heterogeneity (P = 0.88 and I2 = 0%) (Figure 2B).
Four studies assessed positive margins15,16,20,21. Cases were reported with both cold cone 
and LEEP use. In patients treated with cold cone, 16.1% of cases were reported and in those 
treated with LEEP 21.3% of cases were recorded. The meta-analysis of the four studies 
showed that there is no statistically significant risk of positive margins in patients treated 
for CIN with cold cone compared to LEEP (RR 0.77, 95%CI, 0.54–1.09, p = 0.14) (Figure 2C). 
Table 2. Evidence Summary GRADE (1993–2018)
Outcome
Absolute effects Anticipated
Relative Effect 
(95%CI)
Nº of 
participants 
(Studies)
Quality of 
Evidence 
(GRADE)LEEP risk
Cold cone 
risk
Question: Should Cold Cone vs. LEEP be used for treatment of Cervical Intraepithelial Neoplasia (CIN)?
Bibliography: Girardi et al. 1994; Mathevet et al., 1994; Duggan et al., 1999; Takac et al. 1999; Giacalone et al., 1999; Mathevet et al., 2003
Disease Recurrence (monitoring: range 6 months to 118 months) 71 per 1,000
23 per 1,000
(6 to 81)
RR 0.32
(0.09 to 1.14)
287
(3 ECAs)
⨁◯◯◯
VERY LOW a,b
Residual Disease: (monitoring: up to 6 months) 112 per 1,000
61 per 1,000
(34 to 108)
RR 0.54
(0.30 to 0.96)
529
(4 ECAs)
⨁◯◯◯
VERY LOW c,d
Positive Margins 212 per 1,000
164 per 1,000 
(115 to 232)
RR 0.77
(0.54 to 1.09)
553
(4 ECAs)
⨁◯◯◯
VERY LOW c,d,e
Minor bleeding during the first 24 hours after treatment 54 per 1,000
57 per 1,000
(27 to 119)
RR 1.05
(0.50 to 2.21)
469
(4 ECAs)
⨁◯◯◯
VERY LOW c,f
Minor bleeding after the first 24 hours after treatment 88 per 1,000
83 per 1,000
(36 to 187)
RR 0.94
(0.41 to 0.13)
247
(2 ECAs)
⨁◯◯◯
VERY LOW c,f
Cervical Stenosis (monitoring: range 3 months to 24 months) 66 per 1,000
70 per 1,000
(29 to 169)
RR 1.06
(0.44 to 2.58)
529
(4 ECAs)
⨁◯◯◯
VERY LOW c,f
Outcome
Absolute effects Anticipated
Relative Effect 
(95%CI)
Nº of 
participants 
(Studies)
Quality of 
Evidence 
(GRADE)LEEP risk
Cryotherapy 
Risk
Question: Should Cryotherapy vs. LEEP be used for treatment of Cervical Intraepithelial Neoplasia (CIN)?
Bibliography: Mitchell et al., 1998; Chirenje et al., 2001
Disease Recurrence (monitoring: range 6 to 24 months) 77 per 1,000
144 per 1,000
(90 to 229)
RR 1.86
(1.16 to 2.97)
598
(2 ECAs)
⨁◯◯◯
VERY LOW a,b
Residual Disease: (monitoring: up to 6 months) 37 per 1,000
65 per 1,000
(31 to 133)
RR 1.75
(0.85 to 3.60)
596
(2 ECAs)
⨁◯◯◯
VERY LOW a,b
Minor bleeding during the first 24 hours after treatment 15 per 1,000
4 per 1,000
(1 to 25)
RR 0.27
(0.04 to 1.62)
669
(2 ECAs)
⨁◯◯◯
VERY LOW c,d
Minor bleeding after the first 24 hours after treatment 484 per 1,000
237 per 1,000
(194 to 286)
RR 0.49
(0.40 to 0.59)
625
(2 ECAs)
⨁⨁⨁◯
MODERATE c
Cervical Stenosis: (monitoring: up to 24 months) 3 per 1,000
6 per 1,000
(1 to 68)
RR 1.87
(0.17 to 20.38)
596
(2 ECAs)
⨁◯◯◯
VERY LOW a,d
Pain after 24h post treatment 275 per 1,000
256 per 1,000
(204 to 322)
RR 0.93
(0.74 to 1.17)
625
(2 ECAs)
⨁⨁◯◯
LOW e,f
Infecciones después de 24h post tratamiento 465 per 1,000
544 per 1,000
(502 to 595)
RR 1.17
(1.08 to 1.28)
625
(2 ECAs)
⨁◯◯◯
VERY LOW a,b
GRADE (Degrees of Certainty of Evidence); LEEP: Loop Electrosurgical Excision Procedure
High certainty: we are very sure that the real effect is similar to the estimation of the effect
Moderate certainty: we are moderately confident in the estimate of the effect: the actual effect is likely to be close to the estimate of the effect, but there is 
a possibility that it will be substantially different
Low certainty: our confidence in the estimate of the effect is limited: the actual effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the estimate of the effect: the actual effect is likely to be substantially different from the estimate of 
the effect
a. It was decided to decrease two levels due to High Risk of Wearing Bias (both studies had more than 10% losses)
b. It was decided to decrease one level in imprecision because of the wide CI crossing the 1.25 limit.
c. It was decided to decrease one level for Uncertainty Risk of detection bias (uncertainty in blinding of assessors)
d. It was decided to decrease two levels in inaccuracy because of the wide CI crossing the limits of 0.75 and 1.25 and because of the small number of events.
e. It was decided to decrease one level for Uncertainty Risk of detection (blinding of assessors).
f. It was decided to decrease one level in imprecision because of the wide CI that crosses the 0.75 limit.
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A. Disease Recurrence (monitoring: range 6 months to 118 months)
Study
Cold Cone LEEP
Weight
RR RR
Events Total Events Total Fixed Effects 95%CI Fixed Effects 95%CI
Dugan, 1999 2 67 8 73 79.6% 0.27 (0.06–1.24)
0.1 0.2 0.5 1
Cold Cone LEEP
2 5 10
Girardi, 1994 0 52 0 38 0% Uncountable
Mathevet, 2003 1 28 2 29 20.4% 0.52 (0.05–5.40)
Total (95%CI) 147 140 100% 0.32 (0.09–1.14)
Total events 3
Heterogeneity: Chi2 = 0.02; df = 1 (P = 0.65); I2 = 0%
Total effect test: Z = 1.76 (P = 0.08)
B. Residual Disease: (monitoring: up to 6 months)
Study
Cold Cone LEEP
Weight
RR RR
Events Total Events Total Fixed Effects 95%CI Fixed Effects 95%CI
Dugan, 1999 7 80 14 98 42.5% 0.61 (0.26–1.44)
0.1 0.2 0.5 1
Cold Cone LEEP
2 5 10
Giacalone, 1999 4 38 6 28 23.3% 0.49 (0.15–1.58)
Mathevet, 1994 2 24 2 21 7.2% 0.88 (0.13–5.68)
Takac, 1999 3 120 8 120 27.0% 0.38 (0.10–1.38)
Total (95%CI)  262  267 100% 0.54 (0.30–0.96)
Total events 16  30    
Heterogeneity: Chi2 = 0.67; df = 3 (P = 0.88); I2 = 0%
Total effect test: Z = 2.10 (P = 0.04)
C. Positive Margins
Study
Cold Cone LEEP
Weight
RR RR
Events Total Events Total Fixed Effects 95%CI Fixed Effects 95%CI
Dugan, 1999 20 85 16 89 26.9% 1.31 (0.73–2.35)
0.1 0.2 0.5 1
Cold Cone LEEP
2 5 10
Giacalone, 1999 4 38 2 28 4.0% 1.47 (0.29–7.49)
Mathevet, 1994 10 37 18 36 31.4% 0.54 (0.29–1.01)
Takac, 1999 11 120 22 120 37.8% 0.50 (0.25–0.99)
Total (95%CI) 280  273 100% 0.77 (0.54–1.09)
Total events 45  58   
Heterogeneity: Chi2 = 6.56; df = 3 (P = 0.09); I2 = 54%
Total effect test:  Z = 1.49 (P = 0.14)
D. Minor bleeding during the first 24 hours after treatment
Study
Cold Cone LEEP
Weight
RR RR
Events Total Events Total Fixed Effects 95%CI Fixed Effects 95%CI
Giacalone, 1999 2 38 2 28 18.3% 0.74 (0.11–4.92)
0.1 0.2 0.5 1
Cold Cone LEEP
2 5 10
Girardi, 1994 3 52 2 38 18.3% 1.10 (0.19–6.24)
Mathevet, 1994 0 37 0 36 0% Not estimated
Takac, 1999 9 120 8 120 63.4% 1.13 (0.45–2.82)
Total (95%CI)  247  222 100% 1.05 (0.50–2.21)
Total events 14  12    
Heterogeneity:  Chi2 = 0.16; df = 2 (P = 0.92); I2 = 0%
Total effect test: Z = 0.13 (P = 0.90)
Figure 2. Treatment of cervical intraepithelial neoplasia (CIN) with cold cone versus Loop Electrosurgical Excision Procedure (LEEP).
(Continue)
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The studies showed moderate heterogeneity (P = 0.09 and I2 = 54%), so a sensitivity analysis 
using random effects was performed, and there was no significant change in result (RR 0.77, 
95%CI, 0.44–1.35, p = 0.36).
Four included studies assessed this outcome15,16,20,21. The prevalence of minor bleeding 
in patients treated with cold cone was 5.7% and in those treated with LEEP 5.4%. After 
meta-analysis of the five studies, the risk of minor bleeding during the first 24 hours after 
treatment in patients treated with cold cone versus LEEP was not statistically significant 
(RR 1.05, 95%CI, 0.50–2.21, p = 0.90). No significant heterogeneity of the included studies 
was identified (P = 0.92 and I2 = 0%) (Figure 2D).
Two studies assessed minor bleeding after the first 24 post-treatment16,19. 8.2% of patients 
treated with cold cone reported minor bleeding events after 24 hours of treatment, the 
prevalence of this event in patients treated with LEEP was 8.8%. After meta-analysis of the 
studies, the risk of minor bleeding after the first 24 hours after treatment in patients treated 
with cold cone versus LEEP was not statistically significant (RR, 0.94, 95%CI, 0.41–2.13, 
p = 0.88). No significant heterogeneity of the included studies was identified (P = 0.97 and 
I2 = 0%) (Figure 2E).
Three studies assessed cervical stenosis15,16,19. The prevalence after cold cone treatment was 
6.9% and 6.5% in patients treated with LEEP. The meta-analysis showed an increased risk 
of cervical stenosis in women treated with cold cone versus LEEP, however this result was 
not statistically significant (RR 1.06, 95%CI 0.44–2.58, p = 0.89). Giacalone et al.15 did not 
identify cases of cervical stenosis in any of the patients treated with cold cone or LEEP. The 
studies showed low heterogeneity (P = 0.30 and I2 = 5%) (Figure 2F).
Dugan et al.19 reported one case of infection at the location of surgery in each group. 
The six studies assessed reported no major bleeding or pain secondary to cold cone 
treatment or LEEP.
For the comparison of CIN treatments with Cryotherapy versus LEEP, we identified 
two studies17,18. Both studies reported 14.7% disease recurrence in patients treated 
with cryotherapy and 7.7% of those treated with LEEP. The meta-analysis showed an 
Figure 2. Treatment of cervical intraepithelial neoplasia (CIN) with cold cone versus Loop Electrosurgical Excision Procedure (LEEP). (Continuation)
E. Minor bleeding after the first 24 hours after treatment
Study
Cold Cone LEEP
Weight
RR RR
Events Total Events Total Fixed Effects 95%CI Fixed Effects 95%CI
Duggan, 1999 8 85 9 89 81.3% 0.93 (0.38–2.30)
0.1 0.2 0.5 1
Cold Cone LEEP
2 5 10
Mathevet, 1994 2 37 2 36 18.7% 0.97 (0.14–6.54)
Total (95%CI) 122  125 100% 0.94 (0.41–2.13)
Total events 10  11   
Heterogeneity: Chi2 = 0.00; df = 1 (P = 0.97); I2 = 0%
Total effect test: Z = 0.15 (P = 0.88)
F. Cervical Stenosis (monitoring: range 3 months to 24 months)
Study
Cold Cone LEEP
Weight
RR RR
Events Total Events Total Fixed Effects 95%CI Fixed Effects 95%CI
Duggan, 1999 2 67 4 73 47.3% 0.54 (0.10–2.88)
0.1 0.2 0.5 1
Cold Cone LEEP
2 5 10
Giacalone, 1999 0 38 0 28  Not estimated
Mathevet, 1994 7 24 4 21 52.7% 1.53 (0.52–4.51)
Total (95%CI)  129  122 100% 1.06 (0.44–2.58)
Total events 9  8    
Heterogeneity: Chi2 = 1.06; df = 1 (P = 0.30); I2 = 5%
Total effect test: Z = 0.14 (P = 0.89)
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increased risk of disease recurrence in women treated with cryotherapy compared to 
those treated with LEEP (RR 1.86, 95%CI, 1.16–2.97, p = 0.01) (Figure 3A). The studies 
showed moderate heterogeneity (P = 0.14 and I2 = 53%) so a sensitivity analysis using 
random effects was performed, and there was no significant change in outcome (RR 1.86, 
95%CI, 1.16–2.97, p = 0.01).
For treatment with cryotherapy versus LEEP, cases of residual disease were reported in the 
two selected studies. 6.3% of patients treated with cryotherapy and 3.7% of those treated 
with LEEP had this event. The meta-analysis showed an increased risk of residual disease 
in women treated with cryotherapy compared to those treated with LEEP. However, it was 
not statistically significant (RR 1.75, 95%CI, 0.85–3.60, p = 0.13). The studies showed no 
heterogeneity (P = 0.91 and I2 = 0%) (Figure 3B). The prevalence of minor bleeding in patients 
treated with cryotherapy was 0. 3% and 1.5% in those treated with LEEP. After conducting 
the meta-analysis of the studies, the risk of minor bleeding during the first 24 hours after 
treatment in cryotherapy versus LEEP patients was not statistically significant (RR 0.27, 
95%CI, 0.04–1.62, p = 0.15). No significant heterogeneity was identified from the included 
studies (P = 0.91 and I2 = 0%) (Figure 3C).
22.0% of patients treated with cryotherapy reported minor bleeding events within 24 
hours of treatment; the prevalence of this event in patients treated with LEEP was 48.4%. 
After conducting the meta-analysis, cryotherapy patients had a lower risk of bleeding 
after 24 hours of treatment compared to LEEP patients (RR 0.49, 95%CI, 0.40–0.59, 
p < 0.001). No significant heterogeneity was identified from the included studies (P = 0.17 
and I2 = 46%) (Figure 3D).
Chirenje et al.18 did not report cases of cervical stenosis in any of the treatment groups. 
However, Mitchell et al.17 reported two cases in the cryotherapy treated patients (139) and 
one case in the group of patients treated with LEEP (130), with a nonsignificant risk of 
cervical stenosis if treated with cryotherapy compared to LEEP (RR 1.87, 95%CI, 0.17–20.38, 
p = 0.61) (Figure 3E).
The two studies identified reported cases of pain secondary to treatment. The prevalence 
of pain in patients treated with cryotherapy was 23.9 percent and 27.5 percent in those 
treated with LEEP. The meta-analysis did not show a significant risk of pain secondary to 
cryotherapy treatment compared to LEEP (RR 0.93, 95%CI, 0.74–1.17, p = 0.54). The studies 
showed no heterogeneity (P = 0.50 and I2 = 0%).
Both studies reported cases of post-treatment infections. The prevalence in the cryotherapy 
group was 51.1% and in the LEEP group was 46.5%. After meta-analysis of the studies, 
cryotherapy-treated patients were at increased risk for surgical wound infections compared 
to patients treated with LEEP (RR 1.17, 95%CI, 1.08–1.28, p < 0.001). The studies showed no 
heterogeneity (P = 0.87 and I2 = 0%) (Figure 3F).
DISCUSSION
In this systematic review, we identified few randomized controlled studies that assessed 
treatment of CIN with cryotherapy or cold cone compared to LEEP (two and six studies, 
respectively). The studies were of moderate methodological quality. No significant 
heterogeneity was identified among the studies assessed for each of the efficacy and safety 
outcomes, except for positive margins in the studies comparing cold cone versus LEEP and 
for disease recurrence for the studies comparing cryotherapy to LEEP. Meta-analysis of data 
from the included studies showed that cold cone use decreases the risk of residual disease 
compared to LEEP. While the use of cryotherapy increases the risk of disease recurrence and 
infection; however, it reduces the risk of minor bleeding compared to LEEP treatment. In 
contrast to the study by Jiang et al.24, we found that there is a lower risk of residual disease 
in patients treated with cold cone compared to LEEP. This finding may suggest that the 
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A. Disease Recurrence (monitoring: range 6 to 24 months)
Study
Cold Cone LEEP
Weight
Relative Risk Relative Risk
Events Total Events Total M-H, Fixed Effects 95%CI M-H, Fixed Effects 95%CI
Chirenje, 2001 18 161 6 168 25.1% 3.13 (1.27–7.69)
0.1 0.2 0.5 1
Cryotherapy LEEP
2 5 10
Mitchell, 1998 26 139 17 130 74.9% 1.43 (0.81–2.51)
Total (95%CI) 300 298 100% 1.86 (1.16–2.97)
Total events 44 23
Heterogeneity: Chi2 = 2.12; df = 1 (P = 0.14); I2 = 53%
Total effect test: Z = 2.57 (P = 0.01)
B. Residual Disease
Study
Cold Cone LEEP
Weight
Relative Risk Relative Risk
Events Total Events Total M-H, Fixed Effects 95%CI M-H, Fixed Effects 95%CI
Chirenje, 2001 12 159 7 168 62.2% 1.81 (0.73–4.48)
0.1 0.2 0.5 1
Cryotherapy LEEP
2 5 10
Mitchell, 1998 7 139 4 130 37.8% 1.64 (0.49–5.46)
Total (95%CI)  298  298 100% 1.75 (0.85–3.60)
Total events 19  11   
Heterogeneity: Chi2 = 2.12; df = 1 (P = 0.14); I2 = 53%
Total effect test: Z = 2.57 (P = 0.01)
C. Minor bleeding during the first 24 hours after treatment
Study
Cold Cone LEEP
Weight
Relative Risk Relative Risk
Events Total Events Total M-H, Fixed Effects 95%CI M-H, Fixed Effects 95%CI
Chirenje, 2001 1 200 4 200 72.1% 1.81 (0.73–4.48)
0.01 0.1 1
Cryotherapy LEEP
10 100
Mitchell, 1998 0 139 1 130 27.9% 1.64 (0.49–5.46)
Total (95%CI) 339 330 100% 1.75 (0.85–3.60)
Total events 1  5   
Heterogeneity: Chi2 = 0.01; df = 1 (P = 0.91); I2 = 0%
Total effect test: Z = 1.44 (P = 0.15)
D. Minor Bleeding after 24 hours post-treatment
Study
Cold Cone LEEP
Weight
Relative Risk Relative Risk
Events Total Events Total M-H, Fixed Effects 95%CI M-H, Fixed Effects 95%CI
Chirenje, 2001 68 170 147 186 95.4% 0.51 (0.42–0.62)
0.01 0.1 1
Cryotherapy LEEP
10 100
Mitchell, 1998 0 139 6 130 4.6% 0.07 (0.00–1.27)
Total (95%CI)  309  316 100% 0.49 (0.40–0.59)
Total events 68  153   
Heterogeneity: Chi2 = 1.86; df = 1 (P = 0.17); I2 = 46%
Total effect test: Z = 7.08 (P < 0.0001)
E. Cervical Stenosis: (monitoring: up to 24 months)
Study
Cold Cone LEEP
Weight
Relative Risk Relative Risk
Events Total Events Total M-H, Fixed Effects 95%CI M-H, Fixed Effects 95%CI
Chirenje, 2001 0 159 0 168  Not estimated
0.05 0.2 1
Cryotherapy LEEP
5 20
Mitchell, 1998 2 139 1 130 100% 1.87 (0.17–20.38)
Total (95%CI)  298  298 100% 1.87 (0.17–20.38)
Total events 2  1   
Heterogeneity: Not applicable
Total effect test: Z = 0.51 (P = 0.61)
Figure 3. Treatment of cervical intraepithelial neoplasia (CIN) with cryotherapy versus Loop Electrosurgical Excision Procedure (LEEP).
(Continue)
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technique used could be related to the depth of the extracted tissue, revealed in the positivity 
of the margins, which Jin et al.25 in their meta-analysis, point out as a prognostic factor for 
recurrence and/or residual disease. The systematic review of El-Nashar et al.26 showed a 
lower probability of postoperative bleeding and cervical stenosis in the management of CIN 
with LEEP. Their results show an increase of up to two times in the incidence of disease 
recurrence in patients treated with LEEP compared to those who were treated with cold 
cone. These results are at odds with our findings. We have not identified any differences in 
the management of premalignant lesions with these two methods for the same outcomes. 
This discrepancy can be attributed to the difference in the types of studies included in 
both reviews. The study by El-Nashar et al.26 included both randomized controlled trials 
and observational studies and did not perform stratified analyses for each of these types of 
studies. Since the aim of our study was to assess efficacy and safety, our systematic review 
was restricted to the assessment of RCT.
Our study assessed the effectiveness and safety of managing CIN with cryotherapy 
compared to LEEP. A previous systematic review of controlled studies suggests that the 
rate of disease recurrence (≥ 6 months post-treatment) may be lower after management 
of CIN with LEEP compared to cryotherapy (RR 0.32, 95%CI 0.13–0.78)27. Our review also 
includes the study by Mitchell et al.17 finding a nearly doubled rate of disease recurrence 
with the use of cryotherapy compared to LEEP. Therefore, our study is consistent with the 
evidence of increased risk of disease recurrence with the use of cryotherapy compared 
to LEEP. Similarly, D’Alessandro et al.28 have published a systematic review assessing the 
management of CIN with LEEP and cryotherapy. The results of this study show a lower 
risk of disease recurrence in patients treated with LEEP compared to those treated with 
cryotherapy (RR 0.87; 95%CI, 0.76–0.99). This finding is similar to our review where we 
found the effectiveness of LEEP use to be greater relative to cryotherapy, as we identified an 
increased risk of disease recurrence with the use of cryotherapy. Our study did not include 
Smith et al.29 because they assessed patients with HIV, as well as the Singh et al.30 study 
because it was an observational study. It is essential to note the context in which the two 
included studies conducted the treatments: the professionals were health care workers 
specially trained in the use of both methods, and the care centers were specialized units 
that could increase the chances of success of the procedures. These are important points to 
consider when planning their implementation. The use of cold cone would be the best option 
compared to LEEP in patients with CIN, in terms of residual disease. On the other hand, 
the use of LEEP would be the best option compared to cryotherapy in terms of recurrence 
and post-operative infection. However, this evidence is of very low certainty, according to 
GRADE methodology. The true effect may be substantially different. More randomized 
controlled studies are needed, as well as strict standardized monitoring criteria to establish 
more reliable conclusions to assess the long-term effectiveness and safety of these methods. 
This meta-analysis assesses two treatment methods for CIN (cold cone and cryotherapy) 
compared to LEEP, including only randomized controlled studies to assess their efficacy and 
safety. It thus updates the evidence available to date. The main limitation of this review is 
Figure 3. Treatment of cervical intraepithelial neoplasia (CIN) with cryotherapy versus Loop Electrosurgical Excision Procedure (LEEP). (Continuation)
F. Infections after 24h post treatment
Study
Cold Cone LEEP
Weight
Relative Risk Relative Risk
Events Total Events Total M-H, Fixed Effects 95%CI M-H, Fixed Effects 95%CI
Chirenje, 2001 157 170 146 186 99.3% 1.18 (1.08–1.28)
0.05 0.2 1
Cryotherapy LEEP
5 20
Mitchell, 1998 1 139 1 130 0.7% 0.94 (0.06–14.80)
Total (95%CI) 309  316 100% 1.17 (1.08–1.28)
Total events 158  1
Heterogeneity: Chi2 = 0.03; df = 1 (P = 0.87); I2 = 0%
Total effect test: Z = 3.58 (P = 0.0003)
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that there are few randomized controlled studies, dating back more than 15 years and with 
short monitoring time. However, our systematic review addresses extensively the efficacy 
and safety outcomes with a specific analysis for each of them, thus providing a more refined 
analysis and better evidence for decision making in the therapeutic management of cervical 
intraepithelial neoplastic lesions.
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